Vasopressin and its copilot copeptin in sepsis and septic shock

Critical Care Medicine

Volumn 37, Issue 2, 2009, Pages 749-750

  Russell, James A ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

Cardiac surgery; Copeptin; Sepsis; Septic shock; Survival; Vasopressin levels

Indexed keywords

COPEPTIN; CYSTYL AMINOPEPTIDASE; GLYCOPEPTIDE; UNCLASSIFIED DRUG; VASOPRESSIN;

CARBOXY TERMINAL SEQUENCE; CARDIOGENIC SHOCK; CRITICALLY ILL PATIENT; DOWN REGULATION; EDITORIAL; HEART SURGERY; HEMODYNAMICS; HEMORRHAGIC SHOCK; HORMONE METABOLISM; HORMONE SYNTHESIS; HUMAN; HYPONATREMIA; HYPOTENSION; HYPOTHALAMUS; LOWER RESPIRATORY TRACT INFECTION; PRIORITY JOURNAL; RESUSCITATION; SEPSIS; SEPTIC SHOCK; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE;

ARGININE VASOPRESSIN; CLINICAL TRIALS AS TOPIC; GLYCOPEPTIDES; HUMANS; SEPSIS; SHOCK, SEPTIC; VASOPRESSINS;

EID: 67650360748     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318194d117     Document Type: Editorial

References (17)

1. Landry DW, Levin HR, Gallant EM, et al: Vaso-pressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
2. Patel B, Holmes C, Russell JA, et al: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576-582
3. Russell JA, Walley KR, Singer J, et al: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358: 877-887
4. Coates L, Birch N: Differential cleavage of provasopressin by the major molecular forms of SPC3. J Neurochem 1998; 70:1670-1678
5. Wallis MG, Lankford MF, Keller SR: Vasopres-sin is a physiologic substrate for the insulin-regulated aminopeptidase IRAP. Am J Physiol Endocrinol Metab 2007; 293:E1092-E1102
6. Jochberger S, Dorler J, Luckner G, et al: The vasopressin and copeptin response to infection, severe sepsis, and septic shock. Crit Care Med 2009; 37:476-482
7. Morgentaler NG, Muller B, Struck J, et al: Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemor-rhagic and septic shock. Shock 2007; 28: 219-226
8. Lin IY, Ma HP, Lin AC, et al: Low vasopres-sin/norepinephrine ratio predicts septic shock. Am J Emerg Med 2005; 23:718-724
9. Struck J, Morgentaler NG, Bergmann A: Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 2005; 26:2500 -2504
10. Dunser M, Mayr VD, Wenzel V, et al: Course of vasopressin and copeptin plasma concentrations in a patient with severe septic shock. Anaesth Intensive Care 2006; 34:498 -500
11. Jochberger J, Morgentaler NG, Mayr VD, et al: Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab 2006; 91:4381-4386
12. Jochberger S, Mayr V, Luckner G, et al: Serum vasopressin concentrations in critically ill patients. Crit Care Med 2006; 34:293-299
13. Morgentaler S, Struck J, Alonso C, et al: Assay for the measurement of copeptin, a stable pep-tide derived from the precursor of vasopressin. Clin Chem 2006; 52:112-119
14. Muller B, Morgentaler NG, Stolz P, et al: Circulating levels of copeptin, a novel bi-omarker, in lower respiratory tract infections. Eur J Clin Invest 2007; 37:145-152
15. Lodha R, Vivekanandhan S, Sarthi M, et al: Serial circulating vasopressin levels in children with septic shock. Pediatr Crit Care Med 2006; 7:220-224
16. Schmidt C, Hocherl K, Kurt B, et al: Role of nuclear factor-kappaB- dependent induction of cytokines in the regulation of vasopressin V1A-receptors during cecal ligation and puncture-induced circulatory failure. Crit Care Med 2008; 36:2363-2372
17. Jochberger J, Mayr VD, Luckner G, et al: Vaso-pressin plasma concentrations in post-cardiot-omy shock: A prospective, controlled trial. Intensive Care Med 2007; 33(Suppl 2): A0763